Treatment Overview
A Transrectal Ultrasound (TRUS) biopsy is a minimally invasive diagnostic procedure used to collect prostate tissue samples to check for prostate cancer. In Korea, TRUS biopsies are performed using high-resolution ultrasound imaging, precision biopsy needles, and strict infection-prevention systems. The procedure is recommended when PSA levels rise, MRI shows suspicious lesions, or a digital rectal exam identifies abnormalities. Korean hospitals offer smooth appointment systems, minimal waiting times, and same-day or fast pathology results for international patients.
Purpose & Benefits
The goal of a TRUS biopsy is to accurately identify whether prostate cancer cells are present. Benefits in Korea include:
- High diagnostic accuracy using advanced ultrasound machines.
- Real-time targeting for precise biopsy sampling.
- Early detection of prostate cancer in high-risk individuals.
- Less pain due to improved local anesthesia techniques.
- Low infection rates due to strong sterilization protocols.
- Quick follow-up services and smooth communication with international care teams.
Ideal Candidates
A TRUS biopsy is ideal for:
- Men with elevated PSA levels or rapid PSA changes.
- Patients with abnormal findings during digital rectal exams.
- Individuals with suspicious MRI lesions (PI-RADS).
- Men with a family history of prostate cancer.
- Patients needing a second opinion after unclear results elsewhere.
Korea is especially suitable for international patients who want accurate testing in a safe, technologically advanced medical setting.
Possible Risks & Complications
Although TRUS biopsy is safe, possible risks include:
- Mild bleeding from the rectum, urine, or semen
- Temporary urinary discomfort
- Infection or prostatitis (rare due to strict Korean protocols)
- Urinary retention (very rare)
Korean hospitals use single-use biopsy needles, prophylactic antibiotics, and sterile transrectal techniques to significantly reduce complications.
Techniques & Technology Used
Korea utilizes cutting-edge technology to improve biopsy accuracy:
- High-resolution transrectal ultrasound imaging
- Automated biopsy guns for precise, quick tissue sampling
- Periprostatic nerve block anesthesia for comfort
- Slim biopsy needles to minimize tissue trauma
- MRI–ultrasound fusion-guided biopsies for targeted sampling
Depending on the case, 10–12 core samples are taken to provide a comprehensive analysis.
Treatment Process in Korea
The TRUS biopsy process for foreign patients is efficient and well-coordinated:
- Consultation and review of PSA/MRI results
- Antibiotic preparation and brief rectal cleansing
- Local anesthesia with a periprostatic nerve block
- Gentle insertion of a lubricated ultrasound probe
- Real-time biopsy sampling using a fast needle device
- Short observation time before discharge
- Pathology results available within 1–3 days
Dedicated medical coordinators assist with translation, scheduling, and result explanation.
Recovery & After-Care
Most patients recover quickly and resume normal activities in 24 hours. Korean urology centers provide detailed after-care:
- Drink plenty of water to reduce urinary discomfort
- Avoid strenuous exercise for 24–48 hours
- Continue prescribed antibiotics
- Expect temporary blood in urine or semen
- Seek care if fever or strong pain occurs
Korean hospitals offer reliable post-biopsy support to ensure safe recovery.
Results & Longevity
Biopsy findings are reported using the Gleason Score and Grade Group classifications that help determine the aggressiveness of any detected cancer. Results remain valid for long-term management unless new symptoms arise.
When cancer is confirmed, Korea offers advanced treatment pathways like robotic prostatectomy, radiation therapy, and focal therapy. If results are benign, routine PSA monitoring continues.
Why Korea Is a Top Destination
Korea is a preferred location for TRUS biopsy due to:
- Highly skilled urologists specializing in prostate care
- Low complication rates and world-class safety protocols
- Modern diagnostic technology and accurate sampling systems
- Efficient patient flow and reduced waiting times
- English-speaking international care centers
- Transparent medical prices
International patients benefit from fast, reliable, and well-organized diagnostic services.
Cost Range
The typical TRUS biopsy cost in Korea is:
₩800,000 – ₩1,800,000 KRW
(around $600 – $1,400 USD) depending on the hospital and whether MRI fusion is used. Additional imaging or lab tests may add to the cost.
Popular Clinics in Korea
- Seoul National University Hospital – Urology Center
- Asan Medical Center – Prostate Cancer Division
- Samsung Medical Center – Urology Department
- Gangnam Severance Hospital – Robotic & Diagnostic Urology
- Ewha Womans University Medical Center
- JK Urology & Men’s Health Clinics (international patient-friendly)
